 - PD during or following at least 1 prior treatment. Participants should have received a prior platinum-based 2-drug regimen for locally advanced, unresectable inoperable or metastatic NSCLC or disease recurrence within 6 months of treatment with a platinum-based adjuvantneoadjuvant regimen or combined modality example, chemoradiation regimen with curative intent. 